1. McShea A. Leissle K. Smith MA. The essence of chocolate: a rich, dark, and well-kept secret. Nutrition. 2009;25:1104–1105.
2. World Cocoa Foundation. How chocolate is made. www.worldcocoafoundation.org/learn-about-cocoa/tree-to-table/how-chocolate-is-made.asp. [Jan 10;2010 ]. www.worldcocoafoundation.org/learn-about-cocoa/tree-to-table/how-chocolate-is-made.asp
3. Food and Agriculture Organization of the United Nations. Medium-Term Prospects for Agricultural Commodities: Projections to the Year 2010. 2003. www.fao.org/docrep/006/y5143e/y5143e0x.htm#bm33. [May 10;2010 ]. www.fao.org/docrep/006/y5143e/y5143e0x.htm#bm33
4. Dillinger TL. Barriga P. Escarcega S. Jimenez M. Salazar Lowe D. Grivetti LE. Food of the gods: cure for humanity? A cultural history of the medicinal and ritual use of chocolate. J Nutr. 2000;130:2057S–7072S.
5. Bruinsma K. Taren DL. Chocolate: food or drug? J Am Diet Assoc. 1999;99:1249–1256
6. Hollenberg NK. Martinez G. McCullough M. Meinking T. Passan D. Preston M. Rivera A. Taplin D. Vicaria-Clement M. Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension. 1997;29:171–176.
7. Jenkins DJ. Kendall CW. Vuksan V. Vidgen E. Wong E. Augustin LS. Fulgoni V., 3rd Effect of cocoa bran on low-density lipoprotein oxidation and fecal bulking. Arch Intern Med. 2000;160:2374–2379.
8. Weickert MO. Pfeiffer AF. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr. 2008;138:439–442.
9. Stipanuk M. Biochemical and Physiological Aspects of Human Nutrition. Philadelphia: Saunders Company; 2000.
10. Al-Delaimy WK. Rimm EB. Willett WC. Stampfer MJ. Hu FB. Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr. 2004;23:63–70.
11. Chakraborti S. Chakraborti T. Mandal M. Mandal A. Das S. Ghosh S. Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem. 2002;238:163–179.
12. Olivares M. Uauy R. Copper as an essential nutrient. Am J Clin Nutr. 1996;63:791S–796S.
13. Schwab US. Maliranta HM. Sarkkinen ES. Savolainen MJ. Kesaniemi YA. Uusitupa MI. Different effects of palmitic and stearic acid-enriched diets on serum lipids and lipoproteins and plasma cholesteryl ester transfer protein activity in healthy young women. Metabolism. 1996;45:143–149.
14. McShea A. Ramiro-Puig E. Munro SB. Casadesus G. Castell M. Smith MA. Clinical benefit and preservation of flavonols in dark chocolate manufacturing. Nutr Rev. 2008;66:630–641.
15. Cotelle N. Role of flavonoids in oxidative stress. Curr Top Med Chem. 2001;1:569–590.
16. Schewe T. Steffen Y. Sies H. How do dietary flavanols improve vascular function? A position paper. Arch Biochem Biophys. 2008;476:102–106.
17. Kris-Etherton PM. Keen CL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol. 2002;13:41–49.
18. Schmitt CA. Dirsch VM. Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide. 2009;21:77–91.
19. Manach C. Williamson G. Morand C. Scalbert A. Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005;81:230S–242S.
20. Weisburger JH. Chemopreventive effects of cocoa polyphenols on chronic diseases. Exp Biol Med (Maywood) 2001;226:891–897.
21. Buijsse B. Feskens EJ. Kok FJ. Kromhout D. Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen elderly study. Arch Intern Med. 2006;166:411–417.
22. Janszky I. Mukamal KJ. Ljung R. Ahnve S. Ahlbom A. Hallqvist J. Chocolate consumption and mortality following a first acute myocardial infarction: the Stockholm Heart Epidemiology Program. J Intern Med. 2009;266:248–257.
23. Buijsse B. Weikert C. Drogan D. Bergmann M. Boeing H. Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults. Eur Heart J. 2010;31:1616–1623.
24. Gianfredi, V.; Salvatori, T.; Nucci, D.; Villarini, M.; Moretti, M. Can. chocolate consumption reduce cardio-cerebrovascular risk? Asystematic review and meta-analysis. Nutrition 2018, 46, 103–114. [
25. Lee KW. Kundu JK. Kim SO. Chun KS. Lee HJ. Surh YJ. Cocoa polyphenols inhibit phorbol ester-induced superoxide anion formation in cultured HL-60 cells and expression of cyclooxygenase-2 and activation of NF-kappaB and MAPKs in mouse skin in vivo. J Nutr. 2006;136:1150–1155.
26. Hooper L. Kroon PA. Rimm EB. Cohn JS. Harvey I. Le Cornu KA. Ryder JJ. Hall WL. Cassidy A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38–50.
27. Heiss C. Finis D. Kleinbongard P. Hoffmann A. Rassaf T. Kelm M. Sies H. Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J Cardiovasc Pharmacol. 2007;49:74–80.
28. Pearson DA. Holt RR. Rein D. Paglieroni T. Schmitz HH. Keen CL. Flavanols and platelet reactivity. Clin Dev Immunol. 2005;12:1–9.
29. Grassi D. Desideri G. Necozione S. Lippi C. Casale R. Properzi G. Blumberg JB. Ferri C. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr. 2008;138:1671–1676.
30. Muniyappa R. Hall G. Kolodziej TL. Karne RJ. Crandon SK. Quon MJ. Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. Am J Clin Nutr. 2008;88:1685–1696.
31. Grassi D. Necozione S. Lippi C. Croce G. Valeri L. Pasqualetti P. Desideri G. Blumberg JB. Ferri C. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 2005;46:398–405.
32. Desch S. Schmidt J. Kobler D. Sonnabend M. Eitel I. Sareban M. Rahimi K. Schuler G. Thiele H. Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens. 2010;23:97–103.
33. Davison K. Berry NM. Misan G. Coates AM. Buckley JD. Howe PR. Dose-related effects of flavanol-rich cocoa on blood pressure. J Hum Hypertens. 2010;24:568–576.
34. Ceriello A. Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004;24:816–823.
35. Ruzaidi A. Amin I. Nawalyah AG. Hamid M. Faizul HA. The effect of Malaysian cocoa extract on glucose levels and lipid profiles in diabetic rats. J Ethnopharmacol. 2005;98:55–60.
36. Martín, M.A.; Goya, L.; Ramos, S. Antidiabetic actions of cocoa flavanols. Mol. Nutr. Food Res. 2016, 60,
1756–1769.
37. Ramos, S.; Martín, M.A.; Goya, L. Eects of cocoa antioxidants in type 2 diabetes mellitus. Antioxidants 2017,
6, 84.
38. Tan TYC, Lim XY, Yeo JHH, Lee SWH and Lai NM. Review.The health effects of chocolate and cocoa: a systematic review. Nutrients 2021, 13, 2909, 1-25
39. Angel Garcia-Merino, J.; Moreno-Perezde, D.; Lucas, B.; Montalvo-Lominchar, M.G.; Munoz, E.; Sanchez, L.; Naclerio, F.;Herrera-Rocha, K.M.; Moreno-Jimenez, M.R.; Rocha-Guzman, N.E.; et al. Chronic flavanol-rich cocoa powder supplementation reduces body fat mass in endurance athletes by modifying the follistatin/myostatin ratio and leptin levels. Food Funct. 2020, 11,3441–3450.
40. Kord-Varkaneh, H.; Ghaedi, E.; Nazary-Vanani, A.; Mohammadi, H.; Shab-Bidar, S. Does cocoa/dark chocolate supplementation have favorable effect on body weight, body mass index and waist circumference? A systematic review, meta-analysis and dose-response of randomized clinical trials. Crit. Rev. Food Sci. Nutr. 2019, 59, 2349–2362.
41. Kenny TP. Shu SA. Moritoki Y. Keen CL. Gershwin ME. Cocoa flavanols and procyanidins can modulate the lipopolysaccharide activation of polymorphonuclear cells in vitro. J Med Food. 2009;12:1–7.
42. Ramiro E. Franch A. Castellote C. Andres-Lacueva C. Izquierdo-Pulido M. Castell M. Effect of Theobroma cacao flavonoids on immune activation of a lymphoid cell line. Br J Nutr. 2005;93:859–866.
43. Van den Brink,W.; van Bilsen, J.; Salic, K.; Hoevenaars, F.P.M.; Verschuren, L.; Kleemann, R.; Bouwman, J.;
Ronnett, G.V.; van Ommen, B.; Wopereis, S. Current and Future Nutritional Strategies to Modulate
Inflammatory Dynamics in Metabolic Disorders. Front. Nutr. 2019, 6, 129.
44. Boutron-Ruault, M.C.; Senesse, P.; Faivre, J.; Chatelain, N.; Belghiti, C.; Meance, S. Foods as risk factors for
colorectal cancer: A case-control study in Burgundy (France). Eur. J. Cancer Prev. 1999, 8, 229–235.
45. Yamagishi, M.; Natsume, M.; Osakabe, N.; Okazaki, K.; Furukawa, F.; Imazawa, T.; Nishikawa, A.; Hirose, M.
Chemoprevention of lung carcinogenesis by cacao liquor proanthocyanidins in a male rat multi-organ
carcinogenesis model. Cancer Lett. 2003, 191, 49–57.
46. Schroeter H. Bahia P. Spencer JP. Sheppard O. Rattray M. Cadenas E. Rice-Evans C. Williams RJ. Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. J Neurochem. 2007;101:1596–1606.
47. Wasik, A.; Antkiewicz-Michaluk, L. The mechanism of neuroprotective action of natural compounds.
Pharmacol. Rep. 2017, 69, 851–860.
48. Parker G. Parker I. Brotchie H. Mood state effects of chocolate. J Affect Disord. 2006;92:149–159
